Everyone's cancer is different. A study drug combination that works well for some may not work as well for others.
Bristol Myers Squibb created an innovative clinical trial plan that allows each person who takes part to receive different treatment options, depending on their individual response to the study drugs.
That means, if the first study treatment option that is assigned to you works, that's great! You'll continue with that study treatment. But, if the study treatment option doesn't work well, you may be able to try another study treatment option. We call this clinical trial plan FRACTION.